Although cell therapy has been on its fast lane, all colleagues in this field still have a long way to go due to the difficulty in treatment of solid tumors and the high cost of T cells. It is believed that many people are looking forward to the approval of Chinese cell therapy products.

     Focusing on a number of hot topics such as CAR-T and stem cell therapies, this conference is one of the top-ranked meetings in the field of cell therapy in China. Through participating in it, you can learn more about the the progress of cell therapy, the whole industry and the market of cell therapy in China. 

     Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!